In a issued today, the Government Accountability Office recommended that the Health Resources and Services Administration take additional steps to ensure contract pharmacies comply with 340B drug savings program requirements. Requested by Republican leaders of the House Energy and Commerce Committee, the report reviews the use of contract pharmacies in the 340B program. HRSA concurs in the report with GAO recommendations that it issue guidance on preventing duplicate discounts under Medicaid managed care and assess compliance, and issue more specific guidance regarding contract pharmacy oversight. The agency also agreed with a GAO recommendation to issue guidance on the length of time covered entities must look back following an audit to identify the full scope of noncompliance identified during the audit. HRSA disagreed in the report with a GAO recommendation that it require covered entities to register contract pharmacies for each site of the entity for which a contract exists, and with recommendations that audited covered entities provide certain additional information.

Related News Articles

Headline
The AHA today filed an amicus brief in the U.S. Court of Appeals for the D.C. Circuit, defending the Department of Health and Human Services’ decision to…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Headline
Rep. Doris Matsui, D-Calif., and Sen. Peter Welch, D-Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers'…
Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by AbbVie that the state’s 340B contract…
Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…